| Integration of genetic, clinical, and INR data to refine warfarin dosing P Lenzini, M Wadelius, S Kimmel, JL Anderson, AL Jorgensen, ... Clinical Pharmacology & Therapeutics 87 (5), 572-578, 2010 | 265 | 2010 |
| Combined genetic profiles of components and regulators of the vitamin K-dependent γ-carboxylation system affect individual sensitivity to warfarin M Vecsler, R Loebstein, S Almog, D Kurnik, B Goldman, H Halkin, E Gak Thrombosis and haemostasis 95 (02), 205-211, 2006 | 206 | 2006 |
| Common genetic variants of microsomal epoxide hydrolase affect warfarin dose requirements beyond the effect of cytochrome P450 2C9 R Loebstein, M Vecsler, D Kurnik, N Austerweil, E Gak, H Halkin, S Almog Clinical Pharmacology & Therapeutics 77 (5), 365-372, 2005 | 127 | 2005 |
| Complex drug-drug-disease interactions between amiodarone, warfarin, and the thyroid gland D Kurnik, R Loebstein, Z Farfel, D Ezra, H Halkin, D Olchovsky Medicine 83 (2), 107-113, 2004 | 121 | 2004 |
| Analyzing medical research results based on synthetic data and their relation to real data results: systematic comparison from five observational studies AR Benaim, R Almog, Y Gorelik, I Hochberg, L Nassar, T Mashiach, ... JMIR medical informatics 8 (2), e16492, 2020 | 111 | 2020 |
| Bioavailability of oral vs. subcutaneous low‐dose methotrexate in patients with Crohn's disease D Kurnik, R Loebstein, E Fishbein, S Almog, H Halkin, S Bar‐Meir, ... Alimentary pharmacology & therapeutics 18 (1), 57-63, 2003 | 109 | 2003 |
| Warfarin and vitamin K intake in the era of pharmacogenetics Y Lurie, R Loebstein, D Kurnik, S Almog, H Halkin British journal of clinical pharmacology 70 (2), 164-170, 2010 | 102 | 2010 |
| Over-the-counter vitamin K1-containing multivitamin supplements disrupt warfarin anticoagulation in vitamin K1-depleted patients D Kurnik, R Loebstein, H Rabinovitz, N Austerweil, H Halkin, S Almog Thrombosis and haemostasis 92 (11), 1018-1024, 2004 | 99 | 2004 |
| Differential in vivo sensitivity to inhibition of P-glycoprotein located in lymphocytes, testes, and the blood-brain barrier EF Choo, D Kurnik, M Muszkat, T Ohkubo, SD Shay, JN Higginbotham, ... Journal of Pharmacology and Experimental Therapeutics 317 (3), 1012-1018, 2006 | 97 | 2006 |
| Pharmacogenetic warfarin dose refinements remain significantly influenced by genetic factors after one week of therapy BD Horne, PA Lenzini, M Wadelius, AL Jorgensen, SE Kimmel, PM Ridker, ... Thrombosis and haemostasis 107 (02), 232-240, 2012 | 90 | 2012 |
| Choline transporter gene variation is associated with attention-deficit hyperactivity disorder BA English, MK Hahn, IR Gizer, M Mazei-Robison, A Steele, DM Kurnik, ... Journal of neurodevelopmental disorders 1, 252-263, 2009 | 89 | 2009 |
| Relative contribution of CYP2C9 and VKORC1 genotypes and early INR response to the prediction of warfarin sensitivity during initiation of therapy C Li, UI Schwarz, MD Ritchie, DM Roden, CM Stein, D Kurnik Blood, The Journal of the American Society of Hematology 113 (17), 3925-3930, 2009 | 87 | 2009 |
| The erythromycin breath test reflects P‐glycoprotein function independently of cytochrome P450 3A activity D Kurnik, AJJ Wood, GR Wilkinson Clinical Pharmacology & Therapeutics 80 (3), 228-234, 2006 | 87 | 2006 |
| Increased augmentation index in rheumatoid arthritis and its relationship to coronary artery atherosclerosis. I Avalos, CP Chung, A Oeser, T Gebretsadik, A Shintani, D Kurnik, ... The Journal of Rheumatology 34 (12), 2388-2394, 2007 | 86 | 2007 |
| The association of proton pump inhibitors and hypomagnesemia in the community setting N Markovits, R Loebstein, H Halkin, M Bialik, J Landes‐Westerman, ... The Journal of Clinical Pharmacology 54 (8), 889-895, 2014 | 85 | 2014 |
| Increased warfarin doses and decreased international normalized ratio response after nationwide generic switching H Halkin, J Shapiro, D Kurnik, R Loebstein, V Shalev, E Kokia Clinical Pharmacology & Therapeutics 74 (3), 215-221, 2003 | 73 | 2003 |
| Linearity and stability of intravenous busulfan pharmacokinetics and the role of glutathione in busulfan elimination S Almog, D Kurnik, A Shimoni, R Loebstein, E Hassoun, A Gopher, ... Biology of Blood and Marrow Transplantation 17 (1), 117-123, 2011 | 69 | 2011 |
| a consideration of primaquine dose adjustment for radical cure of Plasmodium vivax malaria. E Schwartz, G Regev-Yochay, D Kurnik The American journal of tropical medicine and hygiene 62 (3), 393-395, 2000 | 68 | 2000 |
| Beta-1-adrenoceptor genetic variants and ethnicity independently affect response to beta-blockade D Kurnik, C Li, GG Sofowora, EA Friedman, M Muszkat, HG Xie, PA Harris, ... Pharmacogenetics and genomics 18 (10), 895-902, 2008 | 64 | 2008 |
| Prescriber response to computerized drug alerts for electronic prescriptions among hospitalized patients YZ Straichman, D Kurnik, I Matok, H Halkin, N Markovits, A Ziv, A Shamiss, ... International Journal of Medical Informatics 107, 70-75, 2017 | 63 | 2017 |
